De novo designed immunotherapeutics
Knockgene biotech
Bring new hope for cancer animals
Our science & platform
When facing complex problems, we need to have a full understanding and analysis of the subject itself in order to find a good solution. This unique understanding and analysis will guide us to think in the right direction. When the direction is right, if you happen to have the right tools, it will be closer to solving the problem.
immunotherapeutics——KN330
In the face of the world-wide problem of tumor, the main problem we think about is how to wake up the animal’s own immune system to fight tumor, rather than increasing additional immune power into animals.
Pipelines
About us
The team
Knockgene was founded by several highly creative scientists from China. The main office locates in Beijing. The team believes that de novo designed drug can treat diseases better. With our unique insights into the immune system and the innovative drug screening platform, we have made some interesting discoveries in the field of immune related diseases. We look forward to finding more drugs with excellent efficacy and reliable safety.
Our mission
The team is committed to developing the first in class immunotherapeutic drugs. The company is established to the development and improvement of the drugs in the companion animal market.
Investment & Cooperation
If you want to invest, patent licensing, joint development cooperation, welcome!